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A B S T R A C T
Background: Postoperative atrial ﬁbrillation (AF) is a serious complication of coronary artery bypass
grafting (CABG). There are scant data on the application of coronary computed tomography angiography
(CCTA) for prediction of postoperative AF.
Methods: A total of 102 patients (77 male, mean age: 64  10 years) with pre-procedural CCTA undergoing
isolated CABG were enrolled. Clinical risk factors were collected. Qualitative and quantitative CCTA analysis
of the atria, pulmonary veins (PV), and epicardial adipose tissue (EAT) along the left atrium (LA) was
performed to determine the predictors for postoperative AF. The primary endpoint was deﬁned as any in-
hospital AF requiring treatment.
Results: Postoperative AF occurred in 24% of patients. Patients with AF had higher body mass index
(29.7  4.8 kg/m2 vs 27.3  3.9 kg/m2, p = 0.013), larger right atrial area (25.4  5.3 cm2 vs 22.3  6.4 cm2,
p = 0.035), LA systolic volume (114.7  32.8 ml vs 96.8  30.4 ml, p = 0.015), LA EAT volume (5.6  3 ml vs
4  2.5 ml, p = 0.009), and right superior PV ostium area (3.8  1.3 cm2 vs 3  1 cm2, p = 0.021) compared to
non-AF patients. By multivariable analysis, only LA EAT volume [odds ratio (OR): 1.21, 95% conﬁdence
interval (CI): 1.01–1.44, p = 0.036] and right superior PV ostium area (OR: 1.63, 95% CI: 1.06–2.50, p = 0.026)
were independent predictors of AF. The optimal cut-offs for LA EAT volume and right superior PV ostium were
>3.4 ml and >4.1 cm2, respectively (max. sensitivity: 83%, max. speciﬁcity: 86%).
Conclusions: Increased LA EAT and right superior PV ostial size are independently associated with AF
after CABG. CCTA might be used as a noninvasive prediction tool for AF in patients undergoing CABG.
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Atrial ﬁbrillation (AF) is the most common arrhythmia after
cardiac surgery affecting approximately 30% of patients undergo-
ing coronary artery bypass grafting (CABG) [1,2]. Its sequelae such
as stroke, heart failure, or worsening of ischemia are not* Corresponding author at: Department of Interventional Cardiology and
Angiology, Institute of Cardiology, Alpejska 42, 04-628 Warsaw, Poland.
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0914-5087/ 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rightsuncommon and might contribute to the increased mortality,
speciﬁcally in the view of the growing risk proﬁle of contemporary
CABG populations [3]. Moreover, a signiﬁcant increase in
healthcare costs associated with a potentially prolonged hospital
stay due to postoperative AF has been reported [4]. Thus,
identifying patients at high risk for developing postoperative AF
would be beneﬁcial both for facilitating preventive measures and
tailored medical interventions.
To date several clinical, laboratory, echocardiographic, and
surgical predictors of postoperative AF have been identiﬁed
[5]. Recently, coronary computed tomography angiography (CCTA)
has become an accurate and routinely used noninvasive tool for reserved.
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features of the atria and pulmonary veins (PVs) [6]. While CCTA has
been successfully employed for the prediction of recurrent AF in
patients undergoing PV ablation [7], data describing its potential
application for the detection of AF after CABG are limited. The
purpose of this investigation was to determine the ability of
preoperative CCTA to predict the onset of AF after CABG in a large
cohort of patients referred for a routine coronary diagnostic work-
up at a single high-volume institution.
Materials and methods
Study design and population
A consecutive series of patients who underwent CCTA before
isolated CABG between June 2008 and July 2013 were included. All
CCTA scans were performed during the 4 weeks prior to CABG. All
patients underwent 12-lead electrocardiogram (ECG), transtho-
racic echocardiography, and coronary angiography as a routine
diagnostic work-up before CABG. The exclusion criteria included
the presence of permanent atrial ﬁbrillation, prior implantation of
a permanent pacemaker or cardioverter deﬁbrillator, signiﬁcant
valvular heart disease requiring concomitant valve surgery, use of
class I or class III anti-arrhythmic agents, and renal dysfunction
(serum creatinine >2.0 mg/dl). All clinical data (including surgical
and anesthesia protocols) and postoperative outcomes were
documented in a prospective database according to local site
protocol, and patient risk stratiﬁcation was determined using the
logistic European System for Cardiac Operative Risk Evaluation
score [8]. Potential predictors of AF were chosen based on a
comprehensive review of the literature [1,2,5]. The study was
approved by the local ethics committee and conducted in
accordance with the declaration of Helsinki.
Study endpoints
The primary endpoint was deﬁned as any new or recurrent AF
during the postoperative hospital stay requiring treatment. Short
and self-limited runs were excluded. After surgery, all patients
were subjected to continuous ECG monitoring for at least 72 h by
using a bedside monitor in the intensive care unit and telemetry on
the cardiothoracic wards. In addition, nursing observations were
repeated every 12 h by measuring blood pressure, pulses, and
assessing the heart rhythm until hospital discharge.
CCTA protocol and image reconstruction
During the study period 2 generations of dual-source computed
tomographic scanners were used (Somatom Deﬁnition CT and
Somatom Deﬁnition Flash CT, Siemens, Erlangen, Germany). Unless
contraindicated, an intravenous or oral dose of metoprolol was
given to target a heart rate of <65 beats/min, and sublingual
nitroglycerin was administered before CCTA scan. The contrast
transit time was estimated by injection of a test bolus. For
acquisition of the volume data set, 80–120 ml iodinated contrast
material (Iomeron 400, Bracco Altana Pharma, Konstanz, Germany)
was injected followed by a mixture of 20% contrast agent and 80%
saline. The scan parameters were as follows and varied according
to the scanner type: beam collimation 64  0.6 mm, tube voltage
100 or 120 mV, gantry rotation time 330 or 280 ms, tube current
330–438 mAs/rotation or 320 mAs/rotation. Dose reduction strat-
egies including ECG-gated tube current modulation and prospec-
tive axial triggering were used to reduce radiation dose whenever
possible. Routine reconstructions of scan data were in mid-to-end
systole and diastole (35–45% and 65–75% of the R–R interval) with
a slice thickness of 0.6 mm and an increment of 0.4 mm.CCTA analysis
CCTA data were evaluated ofﬂine by a highly experienced
reader on a dedicated workstation (Leonardo, Siemens). The CCTA
analysis was performed blinded to all clinical data. The CCTA data
sets were analyzed using multiplanar reconstructed images. For
each patient the 3-chamber view parallel to the left-ventricular
outﬂow tract and the 4-chamber view parallel to the interventi-
cular septum were generated as previously described [9]. In the
3-chamber view, anterior–posterior left atrial (LA) diameter was
measured, whereas in the 4-chamber view, the following
measurements were obtained: superior–inferior and medial–
lateral LA diameters, superior–inferior and medial–lateral right
atrial (RA) diameters, and LA and RA areas. All atrial quantitative
measurements were performed in end-systolic phase of the
cardiac cycle representing the largest atrial cavity [9,10]. LA
volume was determined using a semi-automated software tool
(Volume Viewer, Leonardo, Siemens, Forchheim, Germany) in both
systolic and diastolic cardiac phases. Initially, regions of interests
(ROI) were manually traced every 5 mm in axial multiplanar
reconstructions from the roof of the LA to the level of the mitral
valve with exclusion of the PV and LA appendage. The contour
delineation was checked and manually corrected if necessary in
coronal and sagittal views. A window of 100–1000 Hounsﬁeld
units was applied to exclude parts of the muscular wall and
trabecula within the ROI as previously described [11]. The LA
volume was calculated automatically by summation of pixels
within the ROI and Hounsﬁeld units window using the Simpson’s
rule. The volume and radiodensity of the LA epicardial adipose
tissue (EAT) were calculated with the same software tool by using a
window of 200 to 30 Hounsﬁeld units within the limits of the
pericardial sac in the diastolic phase of the cardiac cycle (Fig. 1)
[12]. To assess the regional characteristics of the LA EAT, the
thickness of the periatrial fat was measured in the short-axis view
at the level of the mid LA as the shortest distance between the LA
wall and three anatomic landmarks: esophagus, main pulmonary
artery, and descending thoracic aorta as previously described
[13]. The LA stroke volume was deﬁned as the difference between
the end-systolic LA volume and the end-diastolic LA volume. The
LA ejection fraction was calculated according to the standard
formula (end-systolic LA volume  end-diastolic LA volume/end-
systolic LA volume)  100%, and then indexed to the body surface
area [10]. Additionally, the number of PV was determined, and the
cross-sectional area of each PV ostium was calculated at the level of
the inﬂection between PV and LA wall (Fig. 2) [14]. All PV
measurements were conducted in the diastolic phase reconstruc-
tion [15]. Finally, the radiodensity ratio of the LA appendage to the
ascending aorta was calculated by measuring a Hounsﬁeld unit
density of 1 cm2 circular ROI placed in the LA appendage and
ascending aorta in order to assess LA ﬁlling disturbances
[16]. Interobserver variability was assessed by a second experi-
enced reader in 25% of all CCTA studies.
Operative protocol
Standard anesthesia was used for all patients. All patients
underwent standard median sternotomy with the intention of
complete coronary revascularization. The type of CABG technique
(off-pump or on-pump CABG) was left to the discretion of the
operator. An initial dose of 1.5 mg/kg heparin sulfate was
administered to maintain an activated clotting time of 250 s
during surgery. Conduits for bypass included the left internal
mammary artery, radial arteries, and/or saphenous vein grafts. The
left internal mammary artery was harvested using the pedicled
technique and was exclusively used to bypass the left anterior
descending coronary artery, whereas radial arteries and/or major
Fig. 1. Calculation of LA EAT volume. Multiplanar axial reconstructions (A) of the LA boundaries with corresponding coronal (B) and sagittal (C) views. The volume of EAT was
automatically calculated by summation of pixels inside the ROI outline (pink line) and pixels within a window of 200 to 30 Hounsﬁeld units (D). EAT, epicardial adipose
tissue; HU, Hounsﬁeld unit; LA, left atrium; ROI, region of interest. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of
the article.)
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branches, and/or right coronary artery. The off-pump CABG was
performed with the use of an Octopus tissue stabilizer (Medtronic,
Inc., Minneapolis, MN, USA). In case of on-pump CABG, myocardial
protection was achieved with ice slush and cold blood cardioplegia,
with a temperature drift to 34 8C. At the termination of CABG,
heparin was antagonized by protamine sulfate. After satisfactory
hemostasis was ensured, the chest was closed and the patient was
transferred to the intensive care unit.
Statistical analysis
Data are expressed as mean  SD for continuous variables and
frequency for categorical variables. Comparison of continuous
variables was performed by using Student’s t-test or the Mann–
Whitney test as appropriate. Differences in categorical data were
analyzed by the Fisher’s exact test. Variables known or suspected to
be associated with the presence of AF were assessed using
univariable and multivariable logistic regression analyses reporting
odds ratios (OR) with 95% conﬁdence intervals (95% CI). Only
variables with p-value <0.05 on univariable analysis were entered in
the multivariable regression model using a backward/forward
selection procedure. Because the history of prior paroxysmal AF
was an important predictor of recurrent AF in previous studies, it was
entered in the second multivariable regression model by forced
entry, regardless of its p-value in the univariable analysis. Receiver
operating characteristics analysis was performed to establish the
optimal CCTA cut-off values to predict the primary endpoint. The
diagnostic performance of CCTA was presented as sensitivity,
speciﬁcity, positive predictive value, negative predictive value,and diagnostic accuracy (true positives + true negatives)/(true
positives + true negatives + false positives + false negatives), with
the corresponding 95% CI. Intra-class correlation coefﬁcient (a
method of agreement for continuous variables) was used to assess
interobserver variability in CCTA-derived predictors for AF. Statisti-
cal signiﬁcance was accepted for two-tailed p-values <0.05.
Statistical analyses were performed with SPSS 20.0 (SPSS Inc.,




A total of 102 CABG patients (mean age: 64  10 years, 75%
male) with preoperative sinus rhythm were enrolled. Postoperative
AF occurred in 24% of patients. Clinical data and medications are
shown in Table 1. Patients with AF had signiﬁcantly higher body mass
index (29.7  4.8 kg/m2 vs 27.3  3.9 kg/m2, p = 0.013) and more
frequent history of prior paroxysmal AF (29% vs 0%, p < 0.001) than
those without AF. The laboratory results, preoperative medications,
and operative data were similar in patients with and without AF.
CCTA characteristics
Table 2 lists CCTA characteristics in relation to postoperative AF.
Patients with AF had signiﬁcantly larger anterior–posterior and
superior–inferior LA diameters, superior–inferior RA diameter, LA
and RA areas, LA end-systolic and end-diastolic volumes, LA EAT
volume, and right superior PV ostium area compared to patients
Fig. 2. Calculation of the PV ostium area. Multiplanar coronal (A), sagittal (B), and axial (C) reconstructions depicting the origin of the right superior PV from the LA. The
resulting area of the PV ostium at the level of the inﬂection between the right superior PV and the LA (D). LA, left atrium; PV, pulmonary vein.
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posterior LA diameter, 0.86 for superior–inferior LA diameter,
0.95 for LA area, 0.96 for RA area, 0.98 for LA end-systolic volume,
0.99 for LA end-diastolic volume, 0.70 for LA EAT volume, and
0.89 for right superior PV ostium area.
Determinants of AF
Table 3 shows predictors of postoperative AF. On univariable
analysis, body mass index, superior–inferior and anterior–posterior
LA diameters, superior–inferior RA diameter, LA and RA areas, LA
end-systolic volume, LA end-systolic volume index, LA EAT volume,
and right superior PV ostium area were signiﬁcant predictors of
AF. The history of prior paroxysmal AF failed to predict the onset of
postoperative AF on univariable analysis (p = 0.999). Multivari-
able analysis yielded right superior PV ostium area (OR: 1.63, 95%
CI: 1.06–2.50, p = 0.026) and LA EAT volume (OR: 1.21, 95% CI:
1.01–1.44, p = 0.036) as the only independent determinants of AF.
In the additional multivariable regression model including prior
paroxysmal AF by forced entry, the right superior PV ostium area
(OR: 1.90, 95% CI: 1.15–3.14, p = 0.012) was the only independent
predictor of AF. In the subanalysis of patients undergoing off-
pump CABG only, both the right superior PV ostium area (OR: 2.07,
95% CI: 1.23–3.49, p = 0.006) and the LA EAT volume (OR: 1.25, 95%
CI: 1.02–1.52, p = 0.028) remained the only independent deter-
minants of AF.
Diagnostic accuracy of CCTA for prediction of AF
The discriminative performance of CCTA variables for predict-
ing AF has been presented by ROC analyses in Fig. 3. The cut-offvalues for prediction of AF were >3.4 ml for the LA EAT volume
[area under the curve (AUC) = 0.66, 95% CI: 0.54–0.79, p < 0.01],
and >4.1 cm2 for the right superior PV ostium area (AUC = 0.67,
95% CI: 0.55–0.79, p < 0.01). In addition, LA end-systolic volume
>128.2 ml (AUC = 0.67, 95% CI: 0.54–0.80, p = 0.01), anterior–
posterior LA diameter >4 cm (AUC = 0.66, 95% CI: 0.52–0.79,
p = 0.02), LA area >29.1 cm2 (AUC = 0.68, 95% CI: 0.55–0.81,
p < 0.01), and RA area >21.8 cm2 (AUC = 0.63, 95% CI: 0.51–0.75,
p = 0.03) also predicted postoperative AF.
Postoperative data
Overall, there were no deaths or strokes during the in-hospital
stay, and the rate of myocardial infarction was similar in patients
with and without AF (0% vs 1%, p = 1.000). The average in-hospital
stay and intensive care unit stay were 10.4  8.3 days and
3.5  1.9 days, respectively, and did not differ signiﬁcantly between
both groups. Patients with AF were less often treated with
angiotensin-converting enzyme inhibitors or angiotensin receptor
blockers (79% vs 95%, p = 0.031) and tended to be more often treated
with amiodarone (21% vs 10%, p = 0.052) compared to patients
without AF. Postoperative data are listed in Table 4.
Discussion
The present study represents the ﬁrst comprehensive CCTA-
based analysis for the prediction of postoperative AF in patients
undergoing isolated CABG. We demonstrate that the CCTA-derived
right superior PV ostium area as well as the EAT volume located
around the LA are independently related to the onset of in-hospital
AF after CABG. Furthermore, as conﬁrmed by the good negative
Table 1
Baseline clinical and operative characteristics of the study population (n = 102).
All patients (n = 102) AF+ (n = 24) AF (n = 78) p-Value
Age, years 64  10 67  8 63  11 0.079
Male 77 (75%) 18 (75%) 59 (76%) 1.000
Body mass index, kg/m2 27.9  4.2 29.7  4.8 27.3  3.9 0.013*
Current smoker 25 (24%) 5 (21%) 20 (26%) 0.788
Hypertension 95 (93%) 21 (87%) 74 (95%) 0.351
Hyperlipidemia 82 (80%) 23 (96%) 69 (88%) 0.445
Diabetes 26 (25%) 7 (29%) 19 (24%) 0.605
Stable angina pectoris 89 (87%) 22 (92%) 67 (86%) 0.728
Heart failure 60 (59%) 15 (62%) 45 (58%) 0.813
Prior paroxysmal atrial ﬁbrillation 7 (7%) 7 (29%) 0 <0.001*
Prior myocardial infarction 42 (41%) 11 (46%) 31 (40%) 0.640
Prior stroke 4 (4%) 2 (8%) 2 (3%) 0.235
Prior coronary artery bypass grafting 6 (6%) 2 (8%) 4 (5%) 0.624
Prior percutaneous coronary intervention 29 (28%) 8 (33%) 21 (27%) 0.607
Chronic renal disease 10 (10%) 4 (17%) 6 (8%) 0.240
Thyroid disease 9 (9%) 2 (8%) 7 (9%) 1.000
Gastroesophageal reﬂux disease 4 (4%) 0 4 (5%) 0.570
Chronic obstructive pulmonary disease 6 (6%) 2 (8%) 4 (5%) 0.624
EuroSCORE II, % 1.81  1.9 2.19  2.07 1.69  1.85 0.260
CHA2DS2-VASc score 3.2  1.2 3.5  1 3.1  1.2 0.173
LVEF, % 56  12 54  12 56  11 0.467
Angiographic results (no of vessels with 50% stenosis)
1-Vessel disease 8 (8%) 3 (12%) 5 (6%) 0.388
2-Vessel disease 18 (18%) 3 (12%) 15 (19%) 0.553
3-Vessel or left main disease 77 (75%) 18 (75%) 59 (76%) 1.000
RCA disease 65 (64%) 17 (71%) 48 (61%) 0.473
Medications
Beta-blockers 90 (88%) 20 (83%) 70 (90%) 0.470
Calcium channel blockers 33 (32%) 11 (46%) 22 (28%) 0.136
ACE inhibitors or ARBs 91 (89%) 23 (96%) 68 (87%) 0.451
Statins 96 (94%) 22 (92%) 74 (95%) 0.624
Potassium supplementation 30 (29%) 9 (37%) 21 (27%) 0.320
Magnesium supplementation 3 (3%) 0 3 (4%) 1.000
Laboratory results
Hemoglobin, g/dl 13.6  1.4 13.7  1.5 13.6  1.4 0.824
Creatinine, mmol/l 85.7  20.1 90.3  25.5 84.2  18.1 0.195
Potassium, mmol/l 4.0  0.5 3.9  0.4 4.0  0.6 0.092
Sodium, mmol/l 141.1  2.2 141.3  2.6 141  2.1 0.536
Fasting glucose, mg/dl 121  37 119  28 122  40 0.771
High-density lipoprotein, mmol/l 1.21  0.34 1.19  0.28 1.22  0.36 0.792
Low-density lipoprotein, mmol/l 2.38  0.97 2.13  0.56 2.46  1.06 0.06
Operative data
On-pump coronary artery bypass grafting 16 (16%) 4 (17%) 12 (15%) 1.000
Surgery duration, min 207  66 215  68 205  66 0.521
Emergency operation 6 (6%) 2 (8%) 4 (5%) 0.624
Intra-aortic balloon pump use 4 (4%) 0 4 (5%) 0.570
Number of grafts 2.3  1 2.5  1.1 2.2  1 0.251
Number of arterial grafts 1.0  0.5 1.0  0.5 1.0  0.5 0.891
ACE, angiotensin-converting enzyme; AF, atrial ﬁbrillation; ARB, angiotensin receptor blocker; EuroSCORE, European System for Cardiac Operative Risk Evaluation; LVEF,
left ventricular ejection fraction; RCA, right coronary artery.
* p-Value <0.05.
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gatekeeper for reﬁned AF risk stratiﬁcation in patients undergoing
CABG. The preoperative dimensions of LA, although univariately
associated with postoperative AF, were superseded in multivari-
able analyses.
Prior reports found the incidence of postoperative AF to be
approximately 30% among patients after isolated CABG [1,2], and
slightly exceeded the total incidence of AF in our study (24%). The
disparity in the frequency of AF between the current ﬁndings and
prior data is unsurprising, given the generally lower risk
presentation of CCTA population and strict deﬁnition of postoper-
ative AF excluding non-signiﬁcant and self-limiting runs in our
report.
To date, the determinants of AF in patients undergoing CABG
have been mostly assessed by studies incorporating intraoperative
and echocardiographic data [1,2,5]. CCTA has been introduced as a
useful noninvasive tool that demonstrates high performance for
assessing the anatomical features of PVs and LA, and has beensuccessfully employed in the planning of ablation procedures
[6,17]. In the only study assessing the potential application of CCTA
for prediction of AF after CABG, Drossos et al. reported the total
volume of EAT surrounding the entire heart to be independently
associated with postoperative AF [12]. This corresponds well with
our ﬁndings, not only conﬁrming the independent relationship
between postoperative AF and EAT volume, but also extending
prior observations to the role of regional EAT located around the LA
in the onset of postoperative AF. Of note, the study of Drossos et al.
was limited to application of 4-slice computed tomographic
scanner and examination of only a single CCTA parameter rather
than performance of a comprehensive CCTA analysis [12]. Thus,
only our report introduces noninvasive CCTA as a potential
gatekeeper for reﬁned AF risk stratiﬁcation, as depicted by the
ROC analysis showing good negative predictive value of the LA EAT
volume >3.4 ml for exclusion of postoperative AF. Although the
underlying mechanism of AF in patients with higher burden of EAT
is unclear, several prior reports conﬁrmed a positive association
Table 3
Logistic regression analysis for the prediction of postoperative atrial ﬁbrillation.
Univariable analysis Multivariable analysis
OR 95% CI p-Value OR 95% CI p-Value
Body mass index, kg/m2 1.14 1.02–1.28 0.017
LA EAT volume, ml 1.24 1.05–1.47 0.013 1.21 1.01–1.44 0.036*
LA sup–inf diameter from 4-chamber view, cm 1.87 1.08–3.25 0.025
LA ant–post diameter from 3-chamber view, cm 2.41 1.20–4.83 0.013
LA area from 4-chamber view, cm2 1.09 1.02–1.17 0.009
RA sup–inf diameter from 4-chamber view, cm 1.90 1.06–3.40 0.030
RA area from 4-chamber view, cm2 1.09 1.00–1.19 0.039
LA end-systolic volume, ml 1.02 1.00–1.03 0.021
LA end-systolic volume index, ml/m2 1.03 1.00–1.07 0.033
Right superior PV ostium area, cm2 1.73 1.14–2.61 0.009 1.63 1.06–2.50 0.026*
CI, conﬁdence interval; EAT, epicardial adipose tissue; LA, left atrium; OR, odds ratio; PV, pulmonary vein; RA, right atrium.
* p-Value <0.05.
Table 2
Computed tomographic characteristics of the study population (n = 102).
All patients (n = 102) AF+ (n = 24) AF (n = 78) p-Value
LA med–lat diameter from 4-chamber view, cm 4.5  0.9 4.7  0.8 4.4  0.9 0.111
LA sup–inf diameter from 4-chamber view, cm 5.9  1 6.3  0.9 5.8  1 0.021*
LA ant–post diameter from 3-chamber view, cm 3.8  0.7 4.2  0.8 3.7  0.7 0.010*
LA area from 4-chamber view, cm2 25.5  7.2 29.0  7.2 24.5  6.8 0.006*
RA med–lat diameter from 4-chamber view, cm 4.8  0.8 5.0  0.7 4.8  0.8 0.157
RA sup–inf diameter from 4-chamber view, cm 5.2  0.9 5.6  0.8 5.1  0.9 0.026*
RA area from 4-chamber view, cm2 23.0  6.3 25.4  5.3 22.3  6.4 0.035*
LA end-systolic volume, ml 101.0  31.8 114.7  32.8 96.8  30.4 0.015*
LA end-diastolic volume, ml 88.0  29.7 103.8  33.7 83.1  26.7 0.010*
LA stroke volume, ml 13.0  9.8 10.8  10.6 13.6  9.5 0.223
LA ejection fraction, % 13.1  8.2 10.5  8.7 13.9  7.9 0.071
LA end-systolic volume index, ml/m2 52.6  14.8 58.4  15.9 50.8  14.0 0.026*
LA EAT volume, ml 4.4  2.7 5.6  3.0 4.0  2.5 0.009*
LA EAT attenuation, HU 66.9  17.1 68.9  7.7 66.3  19.0 0.509
LA EAT thickness to pulmonary artery, cm 0.42  0.18 0.44  0.20 0.41  0.18 0.455
LA EAT thickness to esophagus, cm 0.35  0.14 0.37  0.16 0.34  0.14 0.465
LA EAT thickness to thoracic aorta, cm 0.37  0.23 0.37  0.21 0.37  0.24 0.993
LA appendage/ascending aorta attenuation ratio 0.96  0.08 0.94  0.08 0.97  0.07 0.091
Right superior PV ostium area, cm2 3.2  1.2 3.8  1.3 3.0  1 0.021*
Right inferior PV ostium area, cm2 2.5  1 2.5  0.8 2.6  1 0.798
Left superior PV ostium area, cm2 3.3  1.5 3.6  1.8 3.2  1.4 0.227
Left inferior PV ostium area, cm2 2.0  0.8 2.1  0.9 1.9  0.8 0.272
No of left PV 1.7  0.5 1.8  0.7 1.6  0.5 0.225
No of right PV 2.3  0.6 2.2  0.4 2.4  0.7 0.149
AF, atrial ﬁbrillation; EAT, epicardial adipose tissue; LA, left atrium; PV, pulmonary vein; RA, right atrium.
* p-Value <0.05.
M.P. Opolski et al. / Journal of Cardiology 65 (2015) 285–292290between the presence and severity of AF and EAT [13,18,19]. Fur-
thermore, increasing evidence supports EAT as a metabolically
active tissue with a local paracrine effect on the adjacent
myocardium [20]. Indeed, the onset of postoperative AF was
linked to increased levels of numerous inﬂammatory markers
suggesting that inﬂammation plays a role in the pathogenesis of
cardiac arrhythmia [2]. Interestingly, we failed to demonstrate any
relationship between regional characteristics of the LA EAT and AF
after CABG. Hence, whether EAT should be regarded as a trigger or
a marker of postoperative AF remains to be further delineated.
The PV ostia were identiﬁed as an important source of ectopic
beats initiating AF [21]. In the study of Tagawa et al., PV of larger
diameter were more commonly found in patients with AF when
compared to healthy subjects, suggesting a possible association of
PV size and perpetuation of heart rhythm disorder [22]. The
pioneering study by Haı¨ssaguerre et al. introduced radiofre-
quency ablation of PV arrhythmogenic foci as a primary therapy in
patients with AF [21]. Furthermore, decrease in PV ostial size
following PV ablation was associated with maintenance of sinus
rhythm [23]. The potential role of PV size in the pathogenesis of AF
has been corroborated in our study, showing an independentassociation between the right superior PV ostium area and
postoperative AF in patients undergoing isolated CABG. We thus
hypothesize that local inﬂammatory mediators produced by the
LA EAT in response to myocardial damage during CABG may
promote the activation of ectopic foci in the PV ostia. Interestingly,
of all PVs only the right superior PV was related to postoperative
AF in our study. This may be in part explained by a dominant
anatomical pattern of the longest LA myocardial sleeves and
higher distribution of arrhythmogenic foci found in the superior
PVs [24]. Furthermore, in the study of Wei et al. widening of the
superior but not inferior PV was an independent risk factor for the
recurrence of AF after radiofrequency ablation [25]. Whether the
right superior PV reveals higher ectopic activity than the left
superior PV warrants future research.
The relationship between LA dimensions and postoperative AF
has been demonstrated [1,2]. Atrial dilatation reﬂects the extent of
structural remodeling corresponding to stretching of the conduc-
tion pathways and disorganization of myocardial and nodal tissues
[24,25]. Indeed, in accordance with prior observations, we have
demonstrated signiﬁcantly higher atrial dimensions in patients
with postoperative AF. Nevertheless, neither LA dilatation nor RA
Fig. 3. Cut-off values and diagnostic accuracies of CCTA-derived LA ant–post diameter (A), LA area (B), RA area (C), LA end-systolic volume (D), LA EAT volume (E), and right
superior PV ostium area (F) for prediction of postoperative AF. AF, atrial ﬁbrillation; CCTA, coronary computed tomography angiography; EAT, epicardial adipose tissue; LA,
left atrium; NPV, negative predictive value; PPV, positive predictive value; PV, pulmonary vein; RA, right atrium.
Table 4
Postoperative characteristics of the study population (n = 102).
All patients (n = 102) AF+ (n = 24) AF (n = 78) p-Value
Postoperative medications
Beta-blockers 99 (97%) 23 (96%) 76 (97%) 0.557
Calcium channel blockers 41 (40%) 13 (54%) 28 (36%) 0.153
Amiodarone 10 (10%) 5 (21%) 5 (6%) 0.052
ACE inhibitors or ARBs 93 (91%) 19 (79%) 74 (95%) 0.031*
Statins 79 (77%) 18 (75%) 61 (78%) 0.783
Potassium supplementation 97 (95%) 24 (100%) 73 (94%) 0.589
Magnesium supplementation 60 (59%) 17 (71%) 43 (55%) 0.236
Postoperative laboratory results
Potassium, mmol/l 4.2  0.3 4.2  0.4 4.2  0.3 0.854
Sodium, mmol/l 140.0  2.4 140.1  2.7 140.0  2.3 0.807
In-hospital adverse events
Reoperation for bleeding 3 (3%) 0 3 (4%) 1.000
Recurrent angina 3 (3%) 2 (8%) 1 (1%) 0.137
Pulmonary edema 3 (3%) 1 (4%) 2 (3%) 0.557
Respiratory complications 6 (6%) 2 (8%) 4 (5%) 0.624
Infection 6 (6%) 1 (4%) 5 (6%) 1.000
Intensive care unit stay, days 3.5  1.9 3.5  1.1 3.5  2.1 0.926
Hospital stay, days 10.4  8.3 11.6  5.3 10.0  9.1 0.427
ACE, angiotensin-converting enzyme; AF, atrial ﬁbrillation; ARB, angiotensin receptor blocker.
* p-Value <0.05.
M.P. Opolski et al. / Journal of Cardiology 65 (2015) 285–292 291dilatation was an independent predictor for AF in our study,
possibly indicating a stronger inﬂuence of other CCTA variables
from the regression model.
Our study had several limitations. First, this was a retrospec-
tive and single-center experience. Second, we excluded patients
with prior implantation of a pacemaker or cardioverter
deﬁbrillator, signiﬁcant valvular heart disease, and use of class
I or class III anti-arrhythmic agents to rule out their potentialinﬂuence on the detection and occurrence of postoperative AF.
Third, since the majority of our population comprised patients
undergoing off-pump CABG (84%), our conclusions cannot be
viewed as deﬁnitive among subjects referred for on-pump CABG.
Finally, the CCTA data sets were retrospectively reconstructed in
two ﬁxed intervals of the R–R cycle with a potential bias in the
selection of the most accurate end-systolic or end-diastolic
cardiac phases.
M.P. Opolski et al. / Journal of Cardiology 65 (2015) 285–292292Conclusions
In patients undergoing isolated CABG, the right superior PV
ostium area as well as the extent of the EAT volume surrounding
the LA derived from CCTA data sets independently predict the
onset of postoperative AF. These ﬁndings suggest that CCTA is a
useful noninvasive tool for AF risk stratiﬁcation after CABG. Further
prospective studies are needed to assess the value of CCTA for
triage of patients at high risk of developing postoperative AF and
introducing preventive measures.
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